
Inorab L 75mg/20mg Capsule SR
Marketer
H.L Healthcare Pvt Ltd
Salt Composition
Levosulpiride (75mg) + Rabeprazole (20mg)
Overview Inorab L 75mg/20mg Capsule SR
Gastroesophageal reflux disease (GERD), peptic ulcers, and irritable bowel syndrome may be treated with the prescription medication Inorab L 75mg/20mg Sustained-Release Capsules. This medication lessens excessive stomach acid production and prevents its backflow into the esophagus. Dosage and duration are determined by your physician; take it with or without food as directed. Treatment should continue as prescribed; premature discontinuation might lead to symptom recurrence and condition worsening. Inform your healthcare provider about all other medications you're using, as interactions are possible. Common side effects include nausea, abdominal discomfort, diarrhea, gas, constipation, headache, fatigue, and flu-like symptoms; most are transient. Report any concerning side effects immediately. Dizziness and drowsiness may occur; avoid driving or activities requiring alertness until the effects are known. Alcohol should be avoided due to increased drowsiness risk. Lifestyle adjustments – a high-fiber diet, avoidance of trigger foods, increased hydration, and regular exercise – can enhance treatment outcomes. Disclose any kidney or liver conditions, and inform your doctor if you are pregnant, planning pregnancy, or breastfeeding.
Uses of Inorab L 75mg/20mg Capsule SR
Managing gastroesophageal reflux disease (GERD), intestinal ulcers, and irritable bowel syndrome.
Major Benefits of Inorab L 75mg/20mg Capsule SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Inorab L 75mg/20mg SR capsule whole; do not chew, crush, or divide it. Administer this medication on an empty stomach.
Common Side effects of Inorab L 75mg/20mg Capsule SR:
- Nausea
- Stomach pain
- Diarrhea
- Flatulence
- Constipation
- Headache
- Dizziness
- Weakness
- Sleepiness
- Flu-like symptoms
How to use Inorab L 75mg/20mg Capsule SR:
Follow your physician's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Inorab L 75mg/20mg SR Capsule whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
How Inorab L 75mg/20mg Capsule SR works:
Levosulpiride and rabeprazole, at dosages of 75mg and 20mg respectively, are contained within each sustained-release Inorab L capsule.
SAFETY ADVICE
AlcoholUNSAFE
Combining Inorab L 75mg/20mg SR capsules with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Inorab L 75mg/20mg SR Capsules during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Inorab L 75mg/20mg sustained-release capsules with breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Driving ability may be impaired by side effects associated with Inorab L 75mg/20mg sustained-release capsules.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of Inorab L 75mg/20mg sustained-release capsules in individuals with renal impairment. Medical advice is recommended. Nevertheless, preliminary findings indicate that administration to such patients should be approached with prudence.
LiverCAUTION
Patients with severe hepatic impairment should use Inorab L 75mg/20mg sustained-release capsules cautiously. Dosage modification of Inorab L 75mg/20mg sustained-release capsules may be necessary. Physician consultation is advised.
What if you forget to take Inorab L 75mg/20mg Capsule SR :
Should you forget to take a dose of Inorab L 75mg/20mg sustained-release capsules, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Inorab L 75mg/20mg Capsule SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
